Dr Chris Barber

Chris, joined Lhasa in 2011 as Director of Science – a role he filled until June 2017 when he became CEO.

Prior to this, Chris acquired 20 years of experience as a medicinal chemist at Pfizer where he led teams that identified prototype clinical candidates across a range of diseases targeting enzymes, receptors and ion channels.

In his time with Lhasa he has used this experience to help further develop Lhasa’s software to ensure it provides scientifically rigorous, trusted and transparent information to support efficient decision making within the pharmaceutical sector. He has also played a lead role in the development of Sarah Nexus, which was recently recognised with a Queen’s Award for Enterprise in Innovation.

Now as CEO, Chris leads Lhasa Limited so that it may continue to meet the needs of its members by combining robust science and intuitive software with the dedicated support of over 150 staff.